tirzepatide and phentermine vs. GLP-1 Injections: What's the Real Difference? What You Need to Know

Steven Williams & his medical support team at Tri Valley Plastic Surgery

This is not a pre-filled pen with dosing already measured out

Clinical trial data shows that gastrointestinal symptoms like nausea, the most common side effect, typically appear within 24 to 48 hours of the first dose

Sci Adv 2021;7:eabf4291

One such agent that has captured significant attention are GLP-1 agonists

Recommended articles Microbiome-Targeted Therapies as an Adjunct to Traditional Weight Loss Interventions: A Systematic Review and Meta-Analysis Peckmezian T, Garcia-Larsen V, Wilkins K, Mosli RH, BinDhim NF, John GK, Yasir M, Azhar EI, Mullin GE, Alqahtani SA Diabetes, Metabolic Syndrome and Obesity 2022, 15:3777-3798 Published Date: 11 December 2022 Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations Chao AM, Tronieri JS, Amaro A, Wadden TA Drug Design, Development and Therapy 2022, 16:4449-4461 Published Date: 29 December 2022 Baseline Serum BCAAs are Related to the Improvement in Insulin Resistance in Obese People After a Weight Loss Intervention Zhang C, Wang S, Wu Y, Guo Y, Wang X Diabetes, Metabolic Syndrome and Obesity 2023, 16:179-186 Published Date: 19 January 2023 The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity Dalle Grave R Diabetes, Metabolic Syndrome and Obesity 2024, 17:227-230 Published Date: 15 January 2024 Effect of Weight Loss on the Apnea Hypopnea Index is Related to Waist Circumference in Chinese Adults with Overweight and Obesity Ren Y, Cui X, Zhu X, Guo H, Zhou Q, Yuan P, Cheng H, Wu W Diabetes, Metabolic Syndrome and Obesity 2024, 17:453-463 Published Date: 27 January 2024